Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

Clinical trial NCT03638908 · COMPLETED

Trial details

NCT number: NCT03638908
Sponsor: University of Texas Southwestern Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2013-11-01
Primary completion: 2017-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.